Chinese herbal medicines for adverse events of transarterial chemoembolization in patients with primary liver cancer

To assess the benefits and harms of CHM on any adverse events or adverse effects caused by TACE when used for treatment of patients with primary liver cancer.

This is a protocol.

Share/Save
Health topics: